Moneycontrol PRO
you are here: HomeNewsEmkay
emkay
Jump to
467 Results Found
  • Indian Bank Q3 Net Profit to Rs. 257.3 cr: Emkay Jan 20, 2021 06:48 PM IST

    Indian Bank Q3 Net Profit to Rs. 257.3 cr: Emkay

    Net Interest Income (NII) is expected to increase by 25.5 percent Y-o-Y (down 0.3 percent Q-o-Q) to Rs. 4,131.1 crore, according to Emkay.

  • Canara Bank Q3 Net Profit may dip 75.9% YoY to Rs. 184.2 cr: Emkay Jan 20, 2021 06:44 PM IST

    Canara Bank Q3 Net Profit may dip 75.9% YoY to Rs. 184.2 cr: Emkay

    Net Interest Income (NII) is expected to increase by 15.3 percent Y-o-Y (down 2.9 percent Q-o-Q) to Rs. 6,116.5 crore, according to Emkay.

  • Bandhan Bank Q3 Net Profit may dip 5% YoY to Rs. 694.5 cr: Emkay Jan 20, 2021 06:41 PM IST

    Bandhan Bank Q3 Net Profit may dip 5% YoY to Rs. 694.5 cr: Emkay

    Net Interest Income (NII) is expected to increase by 29 percent Y-o-Y (up 3.3 percent Q-o-Q) to Rs. 1,986.9 crore, according to Emkay.

  • AU Small Finance Bank Q3 Net Profit seen up 128.9% YoY to Rs. 435.2 cr: Emkay Jan 20, 2021 06:37 PM IST

    AU Small Finance Bank Q3 Net Profit seen up 128.9% YoY to Rs. 435.2 cr: Emkay

    Net Interest Income (NII) is expected to increase by 16.2 percent Y-o-Y (up 5.1 percent Q-o-Q) to Rs. 589 crore, according to Emkay.

  • RBL Bank Q3 Net Profit seen up 32.4% YoY to Rs. 92.6 cr: Emkay Jan 20, 2021 06:32 PM IST

    RBL Bank Q3 Net Profit seen up 32.4% YoY to Rs. 92.6 cr: Emkay

    Net Interest Income (NII) is expected to increase by 8.5 percent Y-o-Y (up 7.4 percent Q-o-Q) to Rs. 1,000.6 crore, according to Emkay.

  • DCB Bank Q3 Net Profit may dip 43.1% YoY to Rs. 55 cr: Emkay Jan 20, 2021 06:28 PM IST

    DCB Bank Q3 Net Profit may dip 43.1% YoY to Rs. 55 cr: Emkay

    Net Interest Income (NII) is expected to increase by 2.8 percent Y-o-Y (down 0.5 percent Q-o-Q) to Rs. 332.2 crore, according to Emkay.

  • Kotak Mahindra Bank Q3 Net Profit seen up 6.1% YoY to Rs. 1,693.7 cr: Emkay Jan 20, 2021 06:24 PM IST

    Kotak Mahindra Bank Q3 Net Profit seen up 6.1% YoY to Rs. 1,693.7 cr: Emkay

    Net Interest Income (NII) is expected to increase by 13.3 percent Y-o-Y (down 0.7 percent Q-o-Q) to Rs. 3,886.7 crore, according to Emkay.

  • ICICI Bank Q3 Net Profit may dip 10.5% YoY to Rs. 3,712.1 cr: Emkay Jan 20, 2021 06:19 PM IST

    ICICI Bank Q3 Net Profit may dip 10.5% YoY to Rs. 3,712.1 cr: Emkay

    Net Interest Income (NII) is expected to increase by 11.1 percent Y-o-Y (up 1.3 percent Q-o-Q) to Rs. 9,490.6 crore, according to Emkay.

  • Axis Bank Q3 Net Profit seen up 7.1% YoY to Rs. 1,881.9 cr: Emkay Jan 20, 2021 06:12 PM IST

    Axis Bank Q3 Net Profit seen up 7.1% YoY to Rs. 1,881.9 cr: Emkay

    Net Interest Income (NII) is expected to increase by 16.5 percent Y-o-Y (up 2.6 percent Q-o-Q) to Rs. 7,514.9 crore, according to Emkay.

  • Power Gird Corporation Q2 PAT seen up 11.2% YoY to Rs. 2,568.5 cr: Emkay Oct 14, 2019 05:12 PM IST

    Power Gird Corporation Q2 PAT seen up 11.2% YoY to Rs. 2,568.5 cr: Emkay

    Net Sales are expected to increase by 5.8 percent Y-o-Y (up 0.8 percent Q-o-Q) to Rs. 8,759.8 crore, according to Emkay.

  • NHPC Q2 PAT seen up 1.4% YoY to Rs. 1,220 cr: Emkay Oct 14, 2019 05:09 PM IST

    NHPC Q2 PAT seen up 1.4% YoY to Rs. 1,220 cr: Emkay

    Net Sales are expected to decrease by 0.7 percent Y-o-Y (up 2.3 percent Q-o-Q) to Rs. 2,476.8 crore, according to Emkay.

  • JSW Energy Q2 PAT may dip 17.4% YoY to Rs. 249.6 cr: Emkay Oct 14, 2019 05:06 PM IST

    JSW Energy Q2 PAT may dip 17.4% YoY to Rs. 249.6 cr: Emkay

    Net Sales are expected to decrease by 8.2 percent Y-o-Y (down 7.5 percent Q-o-Q) to Rs. 2,231.7 crore, according to Emkay.

  • Gujarat Industries Power Q2 PAT may dip 5.5% YoY to Rs. 64.4 cr: Emkay Oct 14, 2019 05:03 PM IST

    Gujarat Industries Power Q2 PAT may dip 5.5% YoY to Rs. 64.4 cr: Emkay

    Net Sales are expected to decrease by 12.1 percent Y-o-Y (down 10.3 percent Q-o-Q) to Rs. 317.4 crore, according to Emkay.

  • CESC Q2 PAT seen up 3.6% YoY to Rs. 280.8 cr: Emkay Oct 14, 2019 04:59 PM IST

    CESC Q2 PAT seen up 3.6% YoY to Rs. 280.8 cr: Emkay

    Net Sales are expected to increase by 6.5 percent Y-o-Y (up 0.2 percent Q-o-Q) to Rs. 2,364.7 crore, according to Emkay.

  • Torrent Pharma Q2 PAT seen up 8% YoY to Rs. 220.3 cr: Emkay Oct 14, 2019 04:15 PM IST

    Torrent Pharma Q2 PAT seen up 8% YoY to Rs. 220.3 cr: Emkay

    Net Sales are expected to increase by 9.4 percent Y-o-Y (up 2.5 percent Q-o-Q) to Rs. 2,073 crore, according to Emkay.

  • Ipca Labs Q2 PAT seen up 34% YoY to Rs. 160.2 cr: Emkay Oct 14, 2019 04:12 PM IST

    Ipca Labs Q2 PAT seen up 34% YoY to Rs. 160.2 cr: Emkay

    Net Sales are expected to increase by 12.8 percent Y-o-Y (up 11.3 percent Q-o-Q) to Rs. 1,125.4 crore, according to Emkay.

  • Granules Q2 PAT seen up 19% YoY to Rs. 72 cr: Emkay Oct 14, 2019 04:09 PM IST

    Granules Q2 PAT seen up 19% YoY to Rs. 72 cr: Emkay

    Net Sales are expected to increase by 13 percent Y-o-Y (up 10.3 percent Q-o-Q) to Rs. 656.4 crore, according to Emkay.

  • Glenmark Q2 PAT may dip 46% YoY to Rs. 132.8 cr: Emkay Oct 14, 2019 04:07 PM IST

    Glenmark Q2 PAT may dip 46% YoY to Rs. 132.8 cr: Emkay

    Net Sales are expected to increase by 2.4 percent Y-o-Y (up 13.8 percent Q-o-Q) to Rs. 2,642.7 crore, according to Emkay.

  • Dr. Reddy’s Q2 PAT may dip 10% YoY to Rs. 455.9 cr: Emkay Oct 14, 2019 03:56 PM IST

    Dr. Reddy’s Q2 PAT may dip 10% YoY to Rs. 455.9 cr: Emkay

    Net Sales are expected to increase by 9.7 percent Y-o-Y (up 8.4 percent Q-o-Q) to Rs. 4,167.1 crore, according to Emkay.

  • Divi’s Q2 PAT may dip 9% YoY to Rs. 363.7 cr: Emkay Oct 14, 2019 03:53 PM IST

    Divi’s Q2 PAT may dip 9% YoY to Rs. 363.7 cr: Emkay

    Net Sales are expected to increase by 5.4 percent Y-o-Y (up 16.5 percent Q-o-Q) to Rs. 1,354.7 crore, according to Emkay.

  • Cadila Healthcare Q2 PAT may dip 23% YoY to Rs. 321.5 cr: Emkay Oct 14, 2019 03:49 PM IST

    Cadila Healthcare Q2 PAT may dip 23% YoY to Rs. 321.5 cr: Emkay

    Net Sales are expected to increase by 17.4 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 3,475.2 crore, according to Emkay.

  • Aurobindo Q2 PAT seen up 6% YoY to Rs. 675.1 cr: Emkay Oct 14, 2019 03:47 PM IST

    Aurobindo Q2 PAT seen up 6% YoY to Rs. 675.1 cr: Emkay

    Net Sales are expected to increase by 18.8 percent Y-o-Y (up 3.7 percent Q-o-Q) to Rs. 5,645.7 crore, according to Emkay.

  • Cipla Q2 PAT seen up 17% YoY to Rs. 442.8 cr: Emkay Oct 14, 2019 03:44 PM IST

    Cipla Q2 PAT seen up 17% YoY to Rs. 442.8 cr: Emkay

    Net Sales are expected to increase by 7.4 percent Y-o-Y (up 8 percent Q-o-Q) to Rs. 4,308.8 crore, according to Emkay.

  • Lupin Q2 PAT may dip 22% YoY to Rs. 206.5 cr: Emkay Oct 14, 2019 03:41 PM IST

    Lupin Q2 PAT may dip 22% YoY to Rs. 206.5 cr: Emkay

    Net Sales are expected to increase by 6.2 percent Y-o-Y (down 5.1 percent Q-o-Q) to Rs. 4,195.2 crore, according to Emkay.

  • Sun Pharma Q2 PAT seen up 12% YoY to Rs. 1,114.8 cr: Emkay Oct 14, 2019 03:35 PM IST

    Sun Pharma Q2 PAT seen up 12% YoY to Rs. 1,114.8 cr: Emkay

    Net Sales are expected to increase by 15.2 percent Y-o-Y (down 4.6 percent Q-o-Q) to Rs. 7,988.9 crore, according to Emkay.

Sections
ISO 27001 - BSI Assurance Mark